ERBB2 and neoplasm: We firstly compared different distribution of these scores with respect to clinical characteristics as follows: age at diagnosis, ER status, PR status, HER2 status, histological type, menopause status, PAM50 subtypes, pathologic T, N, M, and tumor stage.